News
BFRG
3.140
+0.96%
0.030
Weekly Report: what happened at BFRG last week (0422-0426)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 51.8% to $1.29 during Thursday's after-market session. Fresh2 Group stock rose 10.61% and ResMed stock rose 6.85% in the same session. The company's Q3 earnings came out today.
Benzinga · 6d ago
Weekly Report: what happened at BFRG last week (0415-0419)?
Weekly Report · 04/22 12:07
Weekly Report: what happened at BFRG last week (0408-0412)?
Weekly Report · 04/15 11:57
BullFrog AI Holdings Announces Key Financial Update
TipRanks · 04/09 12:52
Weekly Report: what happened at BFRG last week (0401-0405)?
Weekly Report · 04/08 12:03
BFRG Stock Earnings: Bullfrog AI Hldgs Reported Results for Q4 2023
Bullfrog AI Hldgs reported earnings per share of -17 cents for the fourth quarter of 2023. The company did not report any revenue for the quarter. Bullfrog AI hldgs just reported results for the 4th quarter of 202023. The company reported no revenue.
Investorplace · 04/02 12:52
Weekly Report: what happened at BFRG last week (0325-0329)?
Weekly Report · 04/01 12:00
Weekly Report: what happened at BFRG last week (0318-0322)?
Weekly Report · 03/25 12:03
Weekly Report: what happened at BFRG last week (0311-0315)?
Weekly Report · 03/18 12:01
MNMD, SMR and VERI are among pre market gainers
On the Move MNMD, SMR and VERI are among pre market gainers. CCSC Technology International, Turtle Beach and Lithium Americas are among the day's top pre market risers. MNMD and SMR are among those with positive results from a Phase 1/2 trial.
Seeking Alpha · 03/14 12:07
Weekly Report: what happened at BFRG last week (0304-0308)?
Weekly Report · 03/11 11:57
BullFrog AI Holdings Announces Impactful Corporate Developments
TipRanks · 03/08 13:12
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
BullFrog AI Holdings, Inc. Is a technology-enabled drug development company using artificial intelligence and machine learning to enable the successful development of pharmaceuticals and biologics. The recording of the fireside chat was held on March 5, 2024. The session featured BullFrog's CEO, Vin Singh.
Barchart · 03/08 07:00
Weekly Report: what happened at BFRG last week (0226-0301)?
Weekly Report · 03/04 12:00
BullFrog AI Holdings Announces Market-Impacting Update
TipRanks · 02/26 13:42
Press Release: BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer. BullFrog is a technology-enabled drug development company using artificial intelligence and machine learning to enable the successful development of pharmaceuticals and biologics. Dr. ChITTenden has a distinguished career at the intersection of artificial intelligence, machine learning, drug discovery and biostatistics.
Dow Jones · 02/26 13:00
Weekly Report: what happened at BFRG last week (0219-0223)?
Weekly Report · 02/26 12:18
7 AI Penny Stocks to Double Your Money: February 2024
Penny stocks representing companies integrating AI into products and services hold particularly interesting upside. Penny Shares are known to move upward rapidly and the emergence of AI continues to produce rapid gains. The companies discussed below are speculative and deserve to be treated as such. Foxo Technologies is a good example of a potential AI penny stock.
Investorplace · 02/23 11:50
BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock
BullFrog AI Holdings, Inc. Announced February 21, 2024, the Underwriter's decision to exercise their over-allotment option to purchase 218,382 shares of the Company's common stock. The company uses artificial intelligence and machine learning to develop pharmaceuticals and biologics.
Barchart · 02/21 11:01
More
Webull provides a variety of real-time BFRG stock news. You can receive the latest news about BULLFROG AI HLDGS INC through multiple platforms. This information may help you make smarter investment decisions.
About BFRG
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence / machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.